Literature DB >> 3891892

Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endothelial cell injury.

A E Schorer, P D Rick, W R Swaim, C F Moldow.   

Abstract

Cultured human umbilical vein endothelial cells synthesize the procoagulant, tissue factor, after exposure to bacterial endotoxin. Wild-type lipopolysaccharide from Escherichia coli 0127:B8 stimulates a five- to 20-fold increase in cellular tissue factor. Similarly, rough or incomplete lipopolysaccharide subunits from mutant bacterial strains, or lipid A prepared by mild acid hydrolysis of whole endotoxin, are also stimulatory. In addition, a lipid A biosynthetic precursor, consisting of a phosphorylated glucosamine disaccharide substituted with four beta-hydroxymyristoyl residues, is stimulatory at nanomolar concentrations. Endothelial cell tissue factor is not detectable on the surface of undisrupted cells, but can activate clotting on the cell surface after oxidant-mediated cell injury. The procoagulant, tissue factor, is synthesized by endothelial cells after stimulation mediated by a moiety contained within the lipid A region of lipopolysaccharide. Exposure of clotting factors at the endothelial cell surface after cell injury suggests a mechanism for the microvascular thrombosis associated with disseminated intravascular coagulation with sepsis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891892

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

Review 1.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

2.  Effect of lipopolysaccharides on cultured human endothelial cells. Relationship between tissue factor activity and prostacyclin release.

Authors:  U Delvos; B Janssen; G Müller-Berghaus
Journal:  Blut       Date:  1987-08

3.  Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.

Authors:  S A Gregory; J H Morrissey; T S Edgington
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

4.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

5.  Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression.

Authors:  N S Key; G M Vercellotti; J C Winkelmann; C F Moldow; J L Goodman; N L Esmon; C T Esmon; H S Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 6.  Coagulation disorders in septic shock.

Authors:  L G Thijs; J P de Boer; M C de Groot; C E Hack
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells.

Authors:  N Teysseire; D Arnoux; F George; J Sampol; D Raoult
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 8.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

9.  Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA.

Authors:  P G Tipping; J H Erlich; J Apostolopoulos; N Mackman; D Loskutoff; S R Holdsworth
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

10.  Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line.

Authors:  T A Drake; W Ruf; J H Morrissey; T S Edgington
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.